Go Pro

Cannae (CNNE) Financials

Cannae logo
$14.85 -0.04 (-0.27%)
As of 03:06 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Cannae

Annual Income Statements for Cannae

This table shows Cannae's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-23 -12 109 28 77 1,786 -287 -428 -627 -609 -1,026
Consolidated Net Income / (Loss)
-7.30 -12 93 -11 47 1,760 -286 -430 -324 -310 -525
Net Income / (Loss) Continuing Operations
-10 -14 -57 -8.50 99 1,760 -286 -430 -306 -288 -427
Total Pre-Tax Income
-3.80 5.20 -74 23 238 2,182 -433 -336 -200 -252 -191
Total Operating Income
-12 -2.20 -78 -146 -118 -189 -134 -145 -119 -104 -120
Total Gross Profit
134 126 166 156 157 61 45 31 43 2.90 -8.20
Total Revenue
1,415 1,178 1,157 1,148 1,070 586 742 662 570 453 424
Operating Revenue
1,412 1,178 1,157 1,148 1,070 586 742 662 570 453 424
Total Cost of Revenue
1,281 1,052 991 991 913 524 698 631 527 450 432
Operating Cost of Revenue
1,281 1,052 991 991 913 524 698 631 527 450 432
Total Operating Expenses
146 128 243 302 275 250 178 176 162 107 111
Selling, General & Admin Expense
96 84 101 92 133 117 152 153 143 93 100
Depreciation Expense
50 45 46 46 41 31 27 23 19 13 12
Total Other Income / (Expense), net
8.30 7.40 3.20 168 356 2,370 -300 -191 -82 -148 -71
Interest Expense
5.50 5.20 7.00 4.70 18 9.00 9.80 12 18 12 12
Interest & Investment Income
2.00 3.30 5.30 6.30 16 17 21 2.50 14 4.60 10
Other Income / (Expense), net
12 9.30 4.90 167 358 2,362 -311 -181 -77 -141 -69
Income Tax Expense
-20 -10 -14 15 24 481 -74 -90 -72 3.30 13
Other Gains / (Losses), net
-26 -30 3.40 -16 -115 59 73 -184 -177 -33 -224
Net Income / (Loss) Discontinued Operations
2.80 2.00 149 -2.10 -52 - - - -18 -22 -98
Net Income / (Loss) Attributable to Noncontrolling Interest
16 0.50 -16 -38 -31 -26 0.60 -1.50 -11 -5.50 -12
Basic Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.84 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Weighted Average Basic Shares Outstanding
70.60M 70.60M 70.60M 71.20M 72.20M 85.70M 90.10M 81.60M 73.40M 64.40M 56.50M
Diluted Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.79 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Weighted Average Diluted Shares Outstanding
70.60M 70.60M 70.60M 71.30M 72.40M 85.90M 90.10M 81.60M 73.40M 64.40M 56.50M
Weighted Average Basic & Diluted Shares Outstanding
- 68.90M 70.60M 70.80M 79.52M 91.65M 86.49M 76.26M 72.48M 62.79M 46.32M
Cash Dividends to Common per Share
- - - - - - - - - - $0.54

Quarterly Income Statements for Cannae

This table shows Cannae's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-157 -65 -90 -155 -14 -46 -226 -239 -68 -606 -64
Consolidated Net Income / (Loss)
-171 -56 -92 -155 -18 -46 -115 -241 -71 -99 -36
Net Income / (Loss) Continuing Operations
-171 -56 -75 -149 -16 -46 -39 -230 -60 -99 -36
Total Pre-Tax Income
-185 13 -36 -170 2.90 -48 -17 -136 -6.50 -32 -30
Total Operating Income
-52 -25 -41 -23 -18 -22 -21 -61 -13 -24 -22
Total Gross Profit
12 11 -6.70 6.70 2.80 0.10 -2.00 -17 6.20 4.40 1.10
Total Revenue
144 119 111 118 114 110 103 110 107 103 96
Operating Revenue
144 119 111 118 114 110 103 110 107 103 96
Total Cost of Revenue
132 108 117 111 111 110 105 127 101 99 95
Operating Cost of Revenue
132 108 117 111 111 110 105 127 101 99 95
Total Operating Expenses
63 36 34 30 21 22 19 44 19 29 23
Selling, General & Admin Expense
58 33 31 26 18 19 16 41 17 26 21
Depreciation Expense
5.90 3.40 3.30 3.40 3.30 3.30 3.10 3.00 2.90 2.90 2.60
Total Other Income / (Expense), net
-133 38 4.40 -147 21 -26 4.80 -75 6.70 -7.70 -7.40
Interest Expense
5.80 3.70 2.60 2.00 2.90 4.10 3.80 3.30 3.30 1.50 2.30
Interest & Investment Income
3.40 4.70 2.10 0.70 0.80 1.00 1.40 4.80 1.90 2.00 2.10
Other Income / (Expense), net
-131 37 4.90 -146 23 -23 7.20 -76 8.10 -8.20 -7.20
Income Tax Expense
-41 -17 57 -36 -6.40 -14 20 -1.80 -3.80 -1.60 0.50
Other Gains / (Losses), net
-26 -87 18 -15 -25 -12 -1.90 -96 -58 -68 -5.80
Net Income / (Loss) Discontinued Operations
- - -17 -6.10 -1.50 - -76 -11 -11 - 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-13 8.60 -1.90 0.00 -3.90 0.30 -2.00 -1.70 -2.40 -5.60 -3.70
Basic Earnings per Share
($2.18) ($0.88) ($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70)
Weighted Average Basic Shares Outstanding
72.10M 73.40M 70.80M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M
Diluted Earnings per Share
($2.18) ($0.88) ($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70)
Weighted Average Diluted Shares Outstanding
72.10M 73.40M 70.90M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M
Weighted Average Basic & Diluted Shares Outstanding
70.71M 72.48M 62.77M 62.73M 62.74M 62.79M 62.82M 56.01M 49.29M 46.32M 43.94M
Cash Dividends to Common per Share
- - - - $0.12 - - $0.12 $0.15 - $0.15

Annual Cash Flow Statements for Cannae

This table details how cash moves in and out of Cannae's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
72 -129 99 77 211 191 -639 162 -142 25 51
Net Cash From Operating Activities
11 60 -91 -23 -84 -114 -176 -205 -88 -90 -18
Net Cash From Continuing Operating Activities
11 60 -91 -23 -84 -114 -176 -205 -88 -90 -18
Net Income / (Loss) Continuing Operations
-7.30 -12 93 -11 47 1,760 -286 -430 -324 -310 -525
Consolidated Net Income / (Loss)
-7.30 -12 93 -11 47 1,760 -286 -430 -324 -310 -525
Depreciation Expense
66 63 58 61 55 31 26 23 19 13 12
Amortization Expense
- - - 0.00 39 25 23 22 19 15 15
Non-Cash Adjustments To Reconcile Net Income
45 37 -286 -79 -135 -2,270 263 416 323 221 446
Changes in Operating Assets and Liabilities, net
-92 -27 45 5.10 -89 341 -201 -236 -125 -28 34
Net Cash From Investing Activities
273 -168 92 187 -24 -74 -272 521 53 298 518
Net Cash From Continuing Investing Activities
273 -168 92 187 -24 -74 -272 521 53 298 518
Purchase of Property, Plant & Equipment
-55 -50 -40 -16 -28 -22 -14 -14 -10 -7.00 -10
Purchase of Investments
-34 -46 -5.60 -42 0.00 -325 -1,005 -178 -331 -266 -162
Sale of Property, Plant & Equipment
82 0.00 0.00 4.90 21 4.40 10 9.20 7.30 6.80 1.70
Sale and/or Maturity of Investments
316 78 34 26 37 787 774 350 387 375 59
Other Investing Activities, net
-0.60 -0.70 1.40 56 70 -527 -102 354 0.00 190 630
Net Cash From Financing Activities
-213 -21 98 -86 319 379 -190 -154 -107 -183 -450
Net Cash From Continuing Financing Activities
-213 -21 98 -86 319 379 -190 -154 -107 -183 -450
Repayment of Debt
-31 -45 -36 -124 -291 -109 -236 -225 -58 -29 -143
Repurchase of Common Equity
- - 0.00 0.00 -4.90 -14 -160 -230 -113 -231 -320
Payment of Dividends
-28 -0.70 -0.40 -0.10 -0.90 -0.80 -0.20 -8.10 -0.70 -23 -31
Issuance of Debt
132 77 84 34 367 45 207 309 66 104 45
Other Financing Activities, net
-286 -52 50 -0.20 12 -0.80 -0.20 0.00 -0.20 -3.60 -1.60

Quarterly Cash Flow Statements for Cannae

This table details how cash moves in and out of Cannae's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-55 48 132 -193 115 -29 -5.30 -60 167 -52 -46
Net Cash From Operating Activities
-20 -33 -36 -10 -32 -12 9.10 -22 -22 16 -21
Net Cash From Continuing Operating Activities
-20 -33 -36 -10 -32 -12 9.10 -22 -22 16 -21
Net Income / (Loss) Continuing Operations
-171 -56 -92 -155 -18 -46 -115 -241 -71 -99 -36
Consolidated Net Income / (Loss)
-171 -56 -92 -155 -18 -46 -115 -241 -71 -99 -36
Depreciation Expense
5.90 3.40 3.30 3.40 3.30 3.30 3.10 3.00 2.90 2.90 2.60
Amortization Expense
4.60 5.00 3.40 3.30 3.40 4.40 3.40 3.40 3.50 4.80 3.20
Non-Cash Adjustments To Reconcile Net Income
187 65 -1.30 173 6.90 43 77 195 62 112 13
Changes in Operating Assets and Liabilities, net
-47 -50 50 -35 -28 -17 41 18 -19 -5.50 -3.90
Net Cash From Investing Activities
17 87 195 58 55 -8.80 -7.00 85 416 24 -1.80
Net Cash From Continuing Investing Activities
17 87 195 58 55 -8.80 -7.00 85 416 24 -1.80
Purchase of Property, Plant & Equipment
-2.30 -3.00 -1.30 -1.60 -1.70 -2.40 -1.90 -2.00 -2.50 -4.00 -1.80
Acquisitions
-66 162 -34 - -1.70 36 -30 - -93 - -0.40
Purchase of Investments
-11 -173 -88 -15 -7.60 -156 -2.00 -5.00 -31 -124 -2.10
Sale of Property, Plant & Equipment
- 7.30 1.00 2.40 3.30 0.10 1.70 - - - 0.00
Divestitures
- - 101 31 - - 14 90 -90 - 0.00
Sale and/or Maturity of Investments
174 94 216 41 169 25 12 2.00 632 -587 2.50
Net Cash From Financing Activities
-52 -5.30 -26 -240 92 -8.40 -7.40 -122 -228 -92 -23
Net Cash From Continuing Financing Activities
-52 -5.30 -26 -240 92 -8.40 -7.40 -122 -228 -92 -23
Repayment of Debt
-56 -0.90 -26 -1.60 -0.40 -0.80 -0.50 - -141 -0.70 -0.70
Repurchase of Common Equity
-51 -7.10 - -231 0.20 -0.20 0.00 - -120 -87 -15
Payment of Dividends
-0.10 -0.60 0.00 - -7.50 -7.70 -7.60 -7.80 -8.00 -7.10 -6.90
Issuance of Debt
55 3.40 0.30 0.10 103 0.50 2.30 -1.70 42 2.80 0.20
Other Financing Activities, net
- -0.10 -0.60 - -2.80 -0.20 -1.60 - - - -1.20

Annual Balance Sheets for Cannae

This table presents Cannae's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,473 1,487 1,460 2,092 4,613 3,890 3,126 2,687 2,229 1,309
Total Current Assets
273 350 452 631 844 122 311 177 197 257
Cash & Equivalents
142 246 316 534 725 86 248 106 132 182
Current Deferred & Refundable Income Taxes
- - - - - 0.00 1.90 26 36 49
Other Current Assets
- - - 97 84 36 26 30 24 26
Plant, Property, & Equipment, net
235 219 176 163 146 101 88 59 62 49
Total Noncurrent Assets
966 918 832 1,299 3,623 3,667 2,727 2,451 1,970 1,003
Long-Term Investments
476 490 463 922 1,517 2,370 2,087 1,864 944 818
Noncurrent Note & Lease Receivables
- - - 193 202 172 156 144 136 117
Goodwill
103 203 77 66 53 53 53 53 53 53
Intangible Assets
112 215 92 63 52 27 24 17 15 13
Noncurrent Deferred & Refundable Income Taxes
33 11 24 55 - 0.00 23 82 74 0.60
Other Noncurrent Operating Assets
- - - 0.00 1,799 1,045 385 291 56 1.40
Total Liabilities & Shareholders' Equity
1,473 1,487 1,460 2,092 4,613 3,890 3,126 2,687 2,229 1,309
Total Liabilities
464 334 260 562 828 549 411 378 414 330
Total Current Liabilities
160 250 160 199 202 180 123 108 147 130
Short-Term Debt
11 122 5.90 7.00 11 2.30 2.30 2.50 61 6.30
Accounts Payable
92 101 96 86 93 106 79 74 55 92
Current Deferred Revenue
25 26 26 26 24 23 19 17 16 16
Other Current Liabilities
- - - 42 26 24 23 14 15 15
Total Noncurrent Liabilities
304 84 100 364 626 369 288 270 267 200
Long-Term Debt
93 13 42 120 52 14 95 103 120 65
Other Noncurrent Operating Liabilities
61 63 57 244 249 211 193 168 147 136
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,010 1,153 1,200 1,530 3,785 3,341 2,715 2,309 1,815 979
Total Preferred & Common Equity
894 1,059 1,125 1,489 3,780 3,335 2,719 2,325 1,837 1,012
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
894 1,059 1,125 1,489 3,780 3,335 2,719 2,325 1,837 1,012
Common Stock
0.00 1,130 1,146 1,397 1,876 1,888 1,936 1,977 2,013 2,041
Retained Earnings
0.00 0.20 46 144 1,930 1,643 1,215 901 567 12
Treasury Stock
- 0.00 -0.20 -5.90 -21 -189 -414 -534 -725 -1,047
Accumulated Other Comprehensive Income / (Loss)
-68 -71 -67 -46 -4.90 -7.20 -18 -20 -19 6.50
Noncontrolling Interest
116 94 75 41 5.60 5.80 -3.90 -15 -21 -33

Quarterly Balance Sheets for Cannae

This table presents Cannae's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
3,181 3,133 2,996 2,768 2,610 2,224 2,286 2,096 1,786 1,514 1,240
Total Current Assets
399 313 190 126 336 101 215 774 624 265 209
Cash & Equivalents
371 185 113 58 238 46 161 126 67 234 136
Current Deferred & Refundable Income Taxes
- 0.00 0.00 4.50 25 25 26 11 11 13 48
Other Current Assets
27 23 24 45 26 21 20 20 18 19 25
Plant, Property, & Equipment, net
89 85 79 63 57 64 63 54 53 52 45
Total Noncurrent Assets
2,694 2,735 2,727 2,579 2,217 2,059 2,008 1,269 1,109 1,197 986
Long-Term Investments
2,046 2,109 2,119 2,025 1,824 1,661 1,643 964 816 913 810
Noncurrent Note & Lease Receivables
159 153 150 123 141 140 138 135 132 129 109
Goodwill
53 53 53 53 53 53 53 53 53 53 53
Intangible Assets
24 23 22 22 16 16 15 15 14 14 13
Noncurrent Deferred & Refundable Income Taxes
76 31 48 85 29 63 69 55 55 50 1.00
Other Noncurrent Operating Assets
335 366 335 271 153 126 90 48 39 38 1.10
Total Liabilities & Shareholders' Equity
3,181 3,133 2,996 2,768 2,610 2,224 2,286 2,096 1,786 1,514 1,240
Total Liabilities
456 414 414 403 345 341 423 400 429 332 317
Total Current Liabilities
166 124 128 118 101 99 84 185 225 131 122
Short-Term Debt
13 1.50 5.00 3.10 1.90 0.50 1.90 102 107 6.90 5.80
Accounts Payable
77 77 87 88 70 70 56 54 89 97 87
Current Deferred Revenue
14 15 14 12 15 14 12 14 13 12 15
Other Current Liabilities
23 22 21 16 14 14 14 15 15 15 16
Total Noncurrent Liabilities
289 290 286 284 244 241 339 215 205 201 195
Long-Term Debt
96 100 98 100 77 78 179 69 62 62 65
Other Noncurrent Operating Liabilities
194 190 187 185 166 164 160 147 143 139 130
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,726 2,719 2,582 2,366 2,265 1,884 1,863 1,697 1,357 1,183 922
Total Preferred & Common Equity
2,728 2,725 2,592 2,389 2,282 1,901 1,884 1,720 1,381 1,210 959
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,728 2,725 2,592 2,389 2,282 1,901 1,884 1,720 1,381 1,210 959
Common Stock
1,924 1,946 1,957 1,966 1,985 1,998 2,005 2,021 2,035 2,038 2,044
Retained Earnings
1,187 1,211 1,123 966 805 642 621 447 200 124 -28
Treasury Stock
-363 -414 -475 -527 -491 -722 -725 -726 -839 -960 -1,063
Accumulated Other Comprehensive Income / (Loss)
-21 -17 -14 -16 -17 -18 -17 -21 -16 8.80 6.00
Noncontrolling Interest
-2.00 -6.80 -10 -23 -17 -17 -21 -23 -25 -27 -37

Annual Metrics And Ratios for Cannae

This table displays calculated financial ratios and metrics derived from Cannae's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 49,285,406.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 49,285,406.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -20.83
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% -16.70% -1.85% -0.79% -6.75% -45.26% 26.72% -10.79% -13.91% -20.61% -6.39%
EBITDA Growth
0.00% 7.36% -120.71% 667.59% 305.10% 568.72% -117.73% 28.86% 41.50% -39.27% 25.42%
EBIT Growth
0.00% 2,466.67% -1,122.54% 128.93% 1,043.33% 805.33% -120.44% 26.67% 37.75% -26.68% 22.85%
NOPAT Growth
0.00% 22.08% -721.97% 9.62% -115.45% -39.09% 36.40% -8.31% 17.77% 12.78% -15.33%
Net Income Growth
0.00% -63.01% 877.31% -111.46% 541.51% 3,660.26% -116.27% -50.00% 24.56% 4.32% -69.27%
EPS Growth
0.00% 43.75% 955.56% -74.68% 174.36% 1,842.99% -115.34% -64.58% 18.67% -10.77% -91.97%
Operating Cash Flow Growth
0.00% 443.24% -250.41% 74.75% -267.69% -35.27% -54.61% -16.47% 57.19% -2.62% 79.91%
Free Cash Flow Firm Growth
0.00% 0.00% 39.19% 208.90% -127.15% -2,181.17% 138.01% -37.99% -119.22% 293.09% -32.73%
Invested Capital Growth
0.00% 0.00% 46.99% -55.04% -16.28% 681.70% -42.64% -50.89% -3.27% -47.93% -77.58%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -3.79% 1.83% -15.58% 1.57% -3.81% -6.00% -2.04% -1.53%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 291.90% 54.14% 27.72% -213.20% 41.98% -79.39% -33.82% 13.39%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 154.12% 49.88% 29.39% -249.80% 38.56% -52.25% -28.64% 11.70%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 39.93% -37.37% 3.40% 13.38% 9.85% -3.48% 2.54% -1.79%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 75.23% -28.88% 42.10% -181.13% 24.71% -35.78% 3.24% -11.18%
EPS Q/Q Growth
0.00% 0.00% 0.00% 230.00% -23.57% 31.42% -195.51% 19.97% -29.39% 2.67% -17.31%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -36.80% 18.51% -537.88% 51.74% -172.60% 7.32% -20.60% 19.12% 60.74%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -161.21% -26.84% 3,571.50% -53.81% -131.18% 120.38% 99.96%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -57.75% -47.48% 10.13% -30.84% 6.14% 16.86% -3.80% -52.34%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
9.48% 10.69% 14.32% 13.61% 14.69% 10.48% 6.02% 4.71% 7.54% 0.64% -1.94%
EBITDA Margin
4.61% 5.94% -1.25% 7.17% 31.16% 380.66% -53.26% -42.47% -28.86% -50.63% -38.17%
Operating Margin
-0.86% -0.19% -6.70% -12.71% -10.99% -32.18% -17.99% -21.84% -20.86% -22.92% -28.23%
EBIT Margin
-0.02% 0.60% -6.28% 1.83% 22.44% 371.13% -59.86% -49.21% -35.58% -56.77% -44.55%
Profit (Net Income) Margin
-0.52% -1.01% 8.00% -0.92% 4.37% 300.46% -38.59% -64.88% -56.86% -68.53% -123.91%
Tax Burden Percent
192.11% -228.85% -124.50% -46.90% 19.67% 80.65% 66.14% 128.01% 156.49% 117.51% 275.54%
Interest Burden Percent
1,266.67% 73.24% 102.34% 107.62% 99.08% 100.38% 97.46% 103.01% 102.12% 102.72% 100.95%
Effective Tax Rate
0.00% -200.00% 0.00% 66.37% 10.17% 22.05% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -3.63% -12.09% -12.66% -47.88% -16.57% -7.56% -15.06% -19.11% -22.29% -61.33%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -1.99% -35.28% -17.53% -61.20% -124.24% 0.74% -1.12% -7.51% -8.61% -26.34%
Return on Net Nonoperating Assets (RNNOA)
0.00% 1.27% 20.64% 11.76% 51.30% 82.79% -0.48% 0.87% 6.21% 7.25% 23.77%
Return on Equity (ROE)
0.00% -2.36% 8.55% -0.90% 3.43% 66.22% -8.04% -14.19% -12.90% -15.04% -37.57%
Cash Return on Invested Capital (CROIC)
0.00% -203.63% -50.13% 63.28% -30.16% -171.21% 46.64% 53.21% -15.78% 40.75% 65.41%
Operating Return on Assets (OROA)
0.00% 0.48% -4.90% 1.43% 13.52% 64.83% -10.45% -9.29% -6.98% -10.45% -10.67%
Return on Assets (ROA)
0.00% -0.81% 6.25% -0.72% 2.64% 52.49% -6.74% -12.25% -11.15% -12.62% -29.67%
Return on Common Equity (ROCE)
0.00% -2.09% 7.72% -0.84% 3.28% 65.64% -8.03% -14.18% -12.95% -15.17% -38.30%
Return on Equity Simple (ROE_SIMPLE)
0.00% -1.33% 8.73% -0.94% 3.14% 46.56% -8.59% -15.80% -13.94% -16.89% 0.00%
Net Operating Profit after Tax (NOPAT)
-8.47 -6.60 -54 -49 -106 -147 -93 -101 -83 -73 -84
NOPAT Margin
-0.60% -0.56% -4.69% -4.27% -9.87% -25.09% -12.59% -15.29% -14.60% -16.04% -19.76%
Net Nonoperating Expense Percent (NNEP)
0.00% -1.64% 23.20% 4.87% 13.32% 107.67% -8.29% -13.94% -11.60% -13.68% -34.99%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -3.60% -3.45% -3.64% -7.97%
Cost of Revenue to Revenue
90.52% 89.31% 85.68% 86.39% 85.31% 89.52% 93.98% 95.29% 92.46% 99.36% 101.94%
SG&A Expenses to Revenue
6.81% 7.09% 8.76% 8.00% 12.47% 19.91% 20.43% 23.11% 25.07% 20.62% 23.49%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.33% 10.88% 21.02% 26.32% 25.68% 42.67% 24.01% 26.55% 28.40% 23.56% 26.30%
Earnings before Interest and Taxes (EBIT)
-0.30 7.10 -73 21 240 2,174 -444 -326 -203 -257 -189
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
65 70 -15 82 333 2,230 -395 -281 -165 -229 -162
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.13 1.09 1.79 1.07 0.93 0.58 0.58 0.68 0.76
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.86 1.28 1.96 1.10 0.95 0.60 0.60 0.70 0.81
Price to Revenue (P/Rev)
0.00 0.00 1.03 1.06 2.49 6.88 4.18 2.39 2.38 2.75 1.81
Price to Earnings (P/E)
0.00 0.00 10.97 44.27 34.43 2.26 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.81% 3.48%
Earnings Yield
0.00% 0.00% 9.12% 2.26% 2.90% 44.32% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.25 2.23 6.83 1.16 0.74 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.58 0.47 1.28 3.11 0.90 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 6.50 4.12 0.82 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 25.47 5.72 0.84 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 2.18 0.00 0.00 1.16 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.10 0.12 0.04 0.08 0.02 0.00 0.04 0.05 0.10 0.07
Long-Term Debt to Equity
0.00 0.09 0.01 0.04 0.08 0.01 0.00 0.04 0.04 0.07 0.07
Financial Leverage
0.00 -0.64 -0.58 -0.67 -0.84 -0.67 -0.65 -0.78 -0.83 -0.84 -0.90
Leverage Ratio
0.00 1.46 1.37 1.25 1.30 1.26 1.19 1.16 1.16 1.19 1.27
Compound Leverage Factor
0.00 1.07 1.40 1.35 1.29 1.27 1.16 1.19 1.18 1.22 1.28
Debt to Total Capital
0.00% 9.39% 10.47% 3.85% 7.67% 1.65% 0.49% 3.46% 4.35% 9.07% 6.74%
Short-Term Debt to Total Capital
0.00% 1.02% 9.49% 0.47% 0.42% 0.29% 0.07% 0.08% 0.10% 3.06% 0.60%
Long-Term Debt to Total Capital
0.00% 8.37% 0.99% 3.38% 7.25% 1.36% 0.42% 3.38% 4.25% 6.01% 6.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 10.44% 7.27% 6.02% 2.49% 0.15% 0.17% -0.14% -0.63% -1.06% -3.13%
Common Equity to Total Capital
0.00% 80.17% 82.25% 90.13% 89.84% 98.20% 99.34% 96.68% 96.28% 92.00% 96.39%
Debt to EBITDA
0.00 1.50 -9.30 0.58 0.38 0.03 -0.04 -0.35 -0.64 -0.79 -0.44
Net Debt to EBITDA
0.00 -8.07 42.68 -9.26 -3.99 -0.99 6.17 8.08 11.43 6.95 5.75
Long-Term Debt to EBITDA
0.00 1.33 -0.88 0.51 0.36 0.02 -0.04 -0.34 -0.62 -0.52 -0.40
Debt to NOPAT
0.00 -15.86 -2.49 -0.98 -1.20 -0.43 -0.18 -0.96 -1.26 -2.49 -0.85
Net Debt to NOPAT
0.00 85.55 11.41 15.55 12.58 15.06 26.10 22.45 22.60 21.94 11.10
Long-Term Debt to NOPAT
0.00 -14.14 -0.23 -0.86 -1.14 -0.36 -0.15 -0.94 -1.23 -1.65 -0.77
Altman Z-Score
0.00 0.00 2.84 3.94 4.07 5.35 3.78 2.79 2.62 2.01 1.37
Noncontrolling Interest Sharing Ratio
0.00% 11.52% 9.71% 7.17% 4.26% 0.88% 0.16% 0.03% -0.38% -0.89% -1.94%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 1.71 1.40 2.82 3.18 4.18 0.68 2.53 1.65 1.34 1.98
Quick Ratio
0.00 1.37 1.20 2.36 2.69 3.76 0.48 2.30 1.13 0.94 1.40
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -370 -225 245 -67 -1,518 577 358 -69 133 89
Operating Cash Flow to CapEx
0.00% 121.57% -226.18% -208.18% -1,220.29% -636.31% -5,336.36% -4,021.57% -3,251.85% -45,050.00% -208.05%
Free Cash Flow to Firm to Interest Expense
0.00 -71.17 -32.15 52.14 -3.74 -168.65 58.86 29.08 -3.84 11.44 7.50
Operating Cash Flow to Interest Expense
2.02 11.60 -12.96 -4.87 -4.73 -12.66 -17.97 -16.67 -4.91 -7.77 -1.52
Operating Cash Flow Less CapEx to Interest Expense
6.89 2.06 -18.69 -7.21 -5.12 -14.64 -18.31 -17.09 -5.06 -7.78 -2.25
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.80 0.78 0.78 0.60 0.17 0.17 0.19 0.20 0.18 0.24
Accounts Receivable Turnover
0.00 47.71 38.23 34.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 44.03 36.98 38.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 5.01 5.10 5.82 6.33 3.80 6.02 7.04 7.80 7.51 7.65
Accounts Payable Turnover
0.00 11.50 10.31 10.10 10.03 5.84 7.02 6.84 6.88 6.97 5.89
Days Sales Outstanding (DSO)
0.00 7.65 9.55 10.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 8.29 9.87 9.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 31.73 35.40 36.14 36.39 62.52 52.02 53.40 53.05 52.36 62.00
Cash Conversion Cycle (CCC)
0.00 -15.79 -15.98 -16.04 -36.39 -62.52 -52.02 -53.40 -53.05 -52.36 -62.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 364 534 240 201 1,572 902 443 428 223 50
Invested Capital Turnover
0.00 6.48 2.58 2.96 4.85 0.66 0.60 0.98 1.31 1.39 3.10
Increase / (Decrease) in Invested Capital
0.00 364 171 -294 -39 1,371 -670 -459 -15 -205 -173
Enterprise Value (EV)
0.00 0.00 669 535 1,374 1,822 670 -695 -542 -367 -197
Market Capitalization
0.00 0.00 1,194 1,222 2,661 4,030 3,104 1,581 1,354 1,246 765
Book Value per Share
$0.00 $12.66 $15.01 $15.65 $20.66 $41.24 $37.51 $34.85 $32.87 $29.27 $20.53
Tangible Book Value per Share
$0.00 $9.61 $9.10 $13.30 $18.87 $40.09 $36.61 $33.86 $31.88 $28.18 $19.18
Total Capital
0.00 1,115 1,288 1,248 1,657 3,849 3,358 2,812 2,414 1,996 1,050
Total Debt
0.00 105 135 48 127 64 16 97 105 181 71
Total Long-Term Debt
0.00 93 13 42 120 52 14 95 103 120 65
Net Debt
0.00 -565 -619 -762 -1,329 -2,213 -2,439 -2,272 -1,881 -1,592 -929
Capital Expenditures (CapEx)
-27 50 40 11 6.90 18 3.30 5.10 2.70 0.20 8.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -69 -41 -50 -95 -106 -141 -92 -50 -26 -49
Debt-free Net Working Capital (DFNWC)
0.00 125 223 298 439 654 -56 190 72 111 133
Net Working Capital (NWC)
0.00 113 100 292 432 642 -58 188 70 50 127
Net Nonoperating Expense (NNE)
-1.17 5.30 -147 -38 -152 -1,907 193 328 241 238 441
Net Nonoperating Obligations (NNO)
0.00 -646 -619 -960 -1,329 -2,213 -2,439 -2,272 -1,881 -1,592 -929
Total Depreciation and Amortization (D&A)
66 63 58 61 93 56 49 45 38 28 27
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -5.86% -3.52% -4.31% -8.83% -18.17% -19.05% -13.96% -8.68% -5.81% -11.54%
Debt-free Net Working Capital to Revenue
0.00% 10.57% 19.25% 25.93% 41.05% 111.58% -7.49% 28.73% 12.68% 24.62% 31.42%
Net Working Capital to Revenue
0.00% 9.60% 8.68% 25.42% 40.39% 109.65% -7.80% 28.38% 12.25% 11.14% 29.93%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.84 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Adjusted Weighted Average Basic Shares Outstanding
70.60M 70.60M 70.60M 71.20M 72.20M 85.70M 90.10M 81.60M 73.40M 64.40M 56.50M
Adjusted Diluted Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.79 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Adjusted Weighted Average Diluted Shares Outstanding
70.60M 70.60M 70.60M 71.30M 72.40M 85.90M 90.10M 81.60M 73.40M 64.40M 56.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 68.90M 70.86M 72.22M 79.52M 91.65M 86.49M 76.26M 72.48M 62.79M 46.32M
Normalized Net Operating Profit after Tax (NOPAT)
-8.47 -1.54 -54 -83 -96 -141 -93 -101 -83 -73 -84
Normalized NOPAT Margin
-0.60% -0.13% -4.69% -7.27% -9.00% -24.05% -12.59% -15.29% -14.60% -16.04% -19.76%
Pre Tax Income Margin
-0.27% 0.44% -6.42% 1.97% 22.23% 372.53% -58.34% -50.69% -36.33% -58.32% -44.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.05 1.37 -10.37 4.47 13.49 241.52 -45.34 -26.49 -11.33 -22.15 -15.86
NOPAT to Interest Expense
-1.54 -1.27 -7.75 -10.43 -5.93 -16.33 -9.54 -8.23 -4.65 -6.26 -7.04
EBIT Less CapEx to Interest Expense
4.82 -8.17 -16.10 2.13 13.10 239.53 -45.67 -26.90 -11.48 -22.16 -16.59
NOPAT Less CapEx to Interest Expense
3.33 -10.81 -13.48 -12.77 -6.32 -18.31 -9.87 -8.64 -4.80 -6.28 -7.77
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-376.71% -5.88% 0.43% -0.94% 1.92% 0.05% -0.07% -1.89% -0.22% -7.32% -5.81%
Augmented Payout Ratio
-376.71% -5.88% 0.43% -0.94% 12.39% 0.86% -56.01% -55.31% -35.14% -81.94% -66.72%

Quarterly Metrics And Ratios for Cannae

This table displays calculated financial ratios and metrics derived from Cannae's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - 49,285,406.00 46,324,719.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 49,285,406.00 46,324,719.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -12.30 -1.39
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-12.71% -23.38% -28.26% -22.77% -20.68% -7.88% -6.78% -6.61% -6.15% -6.01% -6.78%
EBITDA Growth
-204.74% -77.86% -173.60% -208.02% 106.97% -279.71% 73.45% 19.42% -88.89% 34.05% -205.19%
EBIT Growth
-218.87% -84.98% -221.43% -172.01% 102.90% -465.04% 60.22% 18.83% -202.00% 28.22% -106.34%
NOPAT Growth
-92.35% -274.41% -38.12% -17.35% -46.35% 72.90% 47.29% -164.78% 84.08% -9.55% -3.27%
Net Income Growth
-409.06% -292.47% -1,230.43% -71.46% 89.74% 18.51% -25.27% -55.16% -304.57% -115.28% 68.87%
EPS Growth
-415.94% -1,077.78% -2,440.00% -114.66% 89.91% 14.77% -42.52% -57.83% -468.18% -178.67% 61.33%
Operating Cash Flow Growth
63.01% -81.97% -82.74% 31.54% -60.30% 63.96% 125.28% -111.76% 32.29% 233.33% -332.97%
Free Cash Flow Firm Growth
-98.34% -109.54% -21.79% 42.05% 467.37% 548.63% -61.42% -35.41% 53.49% -17.78% 60.29%
Invested Capital Growth
-12.15% -3.27% -44.05% -38.48% -36.75% -47.93% -32.08% -53.49% -54.75% -77.58% -70.37%
Revenue Q/Q Growth
-6.02% -16.92% -7.21% 6.59% -3.47% -3.51% -6.10% 6.78% -2.99% -3.37% -6.87%
EBITDA Q/Q Growth
-228.63% 112.02% -240.10% -279.76% 107.43% -410.00% 79.30% -1,597.40% 100.99% -1,992.31% 4.47%
EBIT Q/Q Growth
-195.63% 106.73% -390.24% -241.67% 103.15% -947.17% 68.37% -865.49% 96.28% -533.33% 9.29%
NOPAT Q/Q Growth
-164.80% -56.42% 49.99% 43.35% -230.24% 71.04% 2.73% -184.58% 78.33% -82.58% 8.30%
Net Income Q/Q Growth
-88.72% 67.06% -63.35% -68.85% 88.71% -161.71% -151.09% -109.13% 70.56% -39.27% 63.69%
EPS Q/Q Growth
-87.93% 59.63% -44.32% -96.06% 91.16% -240.91% -141.33% -117.13% 68.19% -67.20% 66.51%
Operating Cash Flow Q/Q Growth
-33.56% -67.34% -8.11% 71.67% -212.75% 62.38% 175.83% -337.36% 0.00% 174.07% -232.50%
Free Cash Flow Firm Q/Q Growth
-85.20% -394.56% 471.81% -12.38% -40.88% 132.92% -68.03% 46.69% 32.10% 32.70% -37.66%
Invested Capital Q/Q Growth
-8.42% 16.86% -44.90% 4.32% -5.85% -3.80% -28.12% -28.57% -8.38% -52.34% -5.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
8.01% 9.39% -6.05% 5.68% 2.46% 0.09% -1.94% -15.25% 5.80% 4.26% 1.14%
EBITDA Margin
-119.92% 17.35% -26.20% -136.78% 10.54% -33.85% -7.46% -118.60% 1.22% -23.81% -24.43%
Operating Margin
-36.14% -20.70% -36.68% -19.49% -15.89% -20.02% -20.74% -55.26% -12.35% -23.33% -22.97%
EBIT Margin
-127.23% 10.31% -32.25% -142.46% 4.65% -40.86% -13.76% -124.41% -4.77% -31.27% -30.46%
Profit (Net Income) Margin
-118.80% -47.11% -82.93% -131.36% -15.36% -41.67% -111.43% -218.24% -66.23% -95.45% -37.21%
Tax Burden Percent
92.17% -422.56% 253.59% 91.50% -546.88% 95.42% 692.77% 177.36% 1,089.23% 310.06% 121.36%
Interest Burden Percent
101.31% 108.13% 101.40% 100.77% 60.38% 106.90% 116.90% 98.91% 127.45% 98.45% 100.68%
Effective Tax Rate
0.00% -130.08% 0.00% 0.00% -193.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-39.15% -62.34% -41.09% -20.75% -72.08% -19.47% -32.60% -93.78% -22.09% -50.68% -64.48%
ROIC Less NNEP Spread (ROIC-NNEP)
-32.92% -62.37% -38.16% -13.48% -74.04% -17.72% -26.99% -80.03% -17.54% -44.20% -62.79%
Return on Net Nonoperating Assets (RNNOA)
27.85% 51.56% 33.12% 11.53% 63.56% 14.92% 24.29% 71.12% 15.60% 39.88% 57.81%
Return on Equity (ROE)
-11.30% -10.78% -7.97% -9.23% -8.51% -4.55% -8.31% -22.65% -6.48% -10.80% -6.67%
Cash Return on Invested Capital (CROIC)
-7.59% -15.78% 27.38% 17.28% 20.13% 40.75% 8.35% 25.52% 26.52% 65.41% 27.52%
Operating Return on Assets (OROA)
-25.94% 2.02% -5.91% -26.83% 0.85% -7.52% -2.60% -27.13% -1.08% -7.49% -7.61%
Return on Assets (ROA)
-24.22% -9.24% -15.20% -24.74% -2.81% -7.67% -21.07% -47.59% -14.99% -22.86% -9.29%
Return on Common Equity (ROCE)
-11.36% -10.82% -8.01% -9.28% -8.60% -4.59% -8.39% -22.95% -6.59% -11.01% -6.82%
Return on Equity Simple (ROE_SIMPLE)
-9.99% 0.00% -17.92% -24.92% -17.01% 0.00% -19.38% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-36 -57 -28 -16 -53 -15 -15 -43 -9.24 -17 -15
NOPAT Margin
-25.30% -47.64% -25.67% -13.64% -46.68% -14.01% -14.52% -38.68% -8.64% -16.33% -16.08%
Net Nonoperating Expense Percent (NNEP)
-6.23% 0.03% -2.93% -7.27% 1.97% -1.75% -5.61% -13.74% -4.55% -6.48% -1.69%
Return On Investment Capital (ROIC_SIMPLE)
- -2.35% -1.21% - - -0.77% -0.80% -2.80% -0.74% -1.61% -1.56%
Cost of Revenue to Revenue
91.99% 90.61% 106.05% 94.32% 97.54% 99.91% 101.94% 115.25% 94.20% 95.74% 98.86%
SG&A Expenses to Revenue
40.04% 27.24% 27.64% 22.29% 15.45% 17.11% 15.79% 37.30% 15.44% 24.78% 21.41%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
44.15% 30.09% 30.62% 25.17% 18.35% 20.11% 18.80% 40.02% 18.15% 27.59% 24.12%
Earnings before Interest and Taxes (EBIT)
-183 12 -36 -168 5.30 -45 -14 -137 -5.10 -32 -29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-172 21 -29 -161 12 -37 -7.70 -131 1.30 -25 -24
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.57 0.58 0.69 0.60 0.63 0.68 0.67 0.95 0.85 0.76 0.55
Price to Tangible Book Value (P/TBV)
0.58 0.60 0.71 0.62 0.66 0.70 0.70 1.00 0.90 0.81 0.59
Price to Revenue (P/Rev)
2.23 2.38 2.98 2.32 2.59 2.75 2.59 3.00 2.38 1.81 1.26
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.66% 1.26% 1.81% 2.62% 2.30% 2.79% 3.48% 5.01%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 1.30 4.99 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.47 1.31 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 12.61 12.40 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.04 0.05 0.04 0.04 0.10 0.10 0.10 0.12 0.06 0.07 0.08
Long-Term Debt to Equity
0.04 0.04 0.03 0.04 0.10 0.07 0.04 0.05 0.05 0.07 0.07
Financial Leverage
-0.85 -0.83 -0.87 -0.86 -0.86 -0.84 -0.90 -0.89 -0.89 -0.90 -0.92
Leverage Ratio
1.17 1.16 1.15 1.17 1.20 1.19 1.19 1.24 1.25 1.27 1.27
Compound Leverage Factor
1.18 1.25 1.17 1.18 0.72 1.27 1.39 1.22 1.59 1.25 1.28
Debt to Total Capital
4.16% 4.35% 3.38% 3.99% 8.87% 9.07% 9.14% 11.04% 5.48% 6.74% 7.08%
Short-Term Debt to Total Capital
0.13% 0.10% 0.08% 0.03% 0.09% 3.06% 5.46% 7.00% 0.55% 0.60% 0.58%
Long-Term Debt to Total Capital
4.03% 4.25% 3.30% 3.96% 8.77% 6.01% 3.67% 4.05% 4.93% 6.14% 6.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.94% -0.63% -0.73% -0.88% -1.04% -1.06% -1.24% -1.62% -2.17% -3.13% -3.68%
Common Equity to Total Capital
96.79% 96.28% 97.35% 96.89% 92.17% 92.00% 92.11% 90.58% 96.69% 96.39% 96.60%
Debt to EBITDA
-1.12 -0.64 -0.34 -0.22 -1.06 -0.79 -0.82 -0.96 -0.37 -0.44 -0.40
Net Debt to EBITDA
21.80 11.43 8.71 4.61 9.53 6.95 4.42 4.05 5.77 5.75 4.93
Long-Term Debt to EBITDA
-1.09 -0.62 -0.33 -0.22 -1.05 -0.52 -0.33 -0.35 -0.33 -0.40 -0.36
Debt to NOPAT
-1.28 -1.26 -0.83 -0.80 -2.43 -2.49 -2.88 -1.97 -0.83 -0.85 -0.83
Net Debt to NOPAT
24.86 22.60 21.19 16.68 21.90 21.94 15.54 8.34 13.10 11.10 10.39
Long-Term Debt to NOPAT
-1.24 -1.23 -0.81 -0.79 -2.41 -1.65 -1.16 -0.72 -0.75 -0.77 -0.77
Altman Z-Score
2.50 2.88 3.43 2.38 2.35 2.33 2.55 2.25 2.35 1.76 1.31
Noncontrolling Interest Sharing Ratio
-0.50% -0.38% -0.48% -0.61% -1.05% -0.89% -1.02% -1.29% -1.59% -1.94% -2.28%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.07 1.65 3.32 1.01 2.55 1.34 4.19 2.78 2.03 1.98 1.71
Quick Ratio
0.65 1.13 2.81 0.55 2.01 0.94 0.68 0.30 1.79 1.40 1.11
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
14 -42 157 138 82 190 61 89 118 156 97
Operating Cash Flow to CapEx
-865.22% 0.00% -12,000.00% 0.00% 0.00% -521.74% 4,550.00% -1,080.00% -864.00% 400.00% -1,177.78%
Free Cash Flow to Firm to Interest Expense
2.48 -11.44 60.53 68.95 28.11 46.32 15.98 26.99 35.65 104.09 42.32
Operating Cash Flow to Interest Expense
-3.43 -9.00 -13.85 -5.10 -11.00 -2.93 2.39 -6.55 -6.55 10.67 -9.22
Operating Cash Flow Less CapEx to Interest Expense
-3.83 -7.84 -13.96 -4.70 -10.45 -3.49 2.34 -7.15 -7.30 8.00 -10.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.20 0.20 0.18 0.19 0.18 0.18 0.19 0.22 0.23 0.24 0.25
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
7.97 7.80 7.41 6.88 7.31 7.51 8.03 7.45 7.47 7.65 8.49
Accounts Payable Turnover
6.87 6.88 6.75 5.96 6.23 6.97 7.08 5.67 5.80 5.89 6.02
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
53.11 53.05 54.07 61.22 58.59 52.36 51.57 64.36 62.91 62.00 60.59
Cash Conversion Cycle (CCC)
-53.11 -53.05 -54.07 -61.22 -58.59 -52.36 -51.57 -64.36 -62.91 -62.00 -60.59
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
367 428 236 246 232 223 160 115 105 50 48
Invested Capital Turnover
1.55 1.31 1.60 1.52 1.54 1.39 2.25 2.42 2.56 3.10 4.01
Increase / (Decrease) in Invested Capital
-51 -15 -186 -154 -135 -205 -76 -132 -127 -173 -113
Enterprise Value (EV)
-672 -542 -476 -516 -456 -367 209 571 -79 -197 -385
Market Capitalization
1,350 1,354 1,570 1,139 1,196 1,246 1,151 1,310 1,026 765 527
Book Value per Share
$32.56 $32.87 $31.49 $30.28 $30.03 $29.27 $27.39 $21.99 $21.60 $20.53 $20.70
Tangible Book Value per Share
$31.54 $31.88 $30.53 $29.18 $28.93 $28.18 $26.31 $20.92 $20.40 $19.18 $19.27
Total Capital
2,468 2,414 2,344 1,962 2,044 1,996 1,867 1,525 1,251 1,050 993
Total Debt
103 105 79 78 181 181 171 168 69 71 70
Total Long-Term Debt
100 103 77 78 179 120 69 62 62 65 65
Net Debt
-1,999 -1,881 -2,029 -1,637 -1,631 -1,592 -919 -714 -1,078 -929 -875
Capital Expenditures (CapEx)
2.30 -4.30 0.30 -0.80 -1.60 2.30 0.20 2.00 2.50 4.00 1.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-66 -50 -48 -53 -37 -26 565 439 -92 -49 -44
Debt-free Net Working Capital (DFNWC)
11 72 236 1.90 133 111 691 506 141 133 92
Net Working Capital (NWC)
7.90 70 234 1.40 131 50 589 399 135 127 86
Net Nonoperating Expense (NNE)
134 -0.63 63 139 -36 30 100 198 62 82 20
Net Nonoperating Obligations (NNO)
-1,999 -1,881 -2,029 -1,637 -1,631 -1,592 -1,536 -1,242 -1,078 -929 -875
Total Depreciation and Amortization (D&A)
11 8.40 6.70 6.70 6.70 7.70 6.50 6.40 6.40 7.70 5.80
Debt-free, Cash-free Net Working Capital to Revenue
-10.82% -8.68% -9.08% -10.72% -8.03% -5.81% 126.90% 100.41% -21.48% -11.54% -10.47%
Debt-free Net Working Capital to Revenue
1.81% 12.68% 44.89% 0.39% 28.69% 24.62% 155.26% 115.67% 32.87% 31.42% 22.11%
Net Working Capital to Revenue
1.30% 12.25% 44.53% 0.28% 28.27% 11.14% 132.34% 91.26% 31.26% 29.93% 20.72%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($2.18) ($0.88) ($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70)
Adjusted Weighted Average Basic Shares Outstanding
72.10M 73.40M 70.80M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M
Adjusted Diluted Earnings per Share
($2.18) ($0.88) ($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70)
Adjusted Weighted Average Diluted Shares Outstanding
72.10M 73.40M 70.90M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
70.71M 72.48M 62.77M 62.73M 62.74M 62.79M 62.82M 56.01M 49.29M 46.32M 43.94M
Normalized Net Operating Profit after Tax (NOPAT)
-36 -17 -28 -16 -13 -15 -15 -43 -9.24 -17 -15
Normalized NOPAT Margin
-25.30% -14.49% -25.67% -13.64% -11.12% -14.01% -14.52% -38.68% -8.64% -16.33% -16.08%
Pre Tax Income Margin
-128.90% 11.15% -32.70% -143.56% 2.81% -43.68% -16.09% -123.05% -6.08% -30.78% -30.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-31.50 3.32 -13.73 -84.05 1.83 -10.95 -3.74 -41.55 -1.55 -21.53 -12.74
NOPAT to Interest Expense
-6.26 -15.36 -10.93 -8.05 -18.33 -3.76 -3.94 -12.92 -2.80 -11.25 -6.73
EBIT Less CapEx to Interest Expense
-31.90 4.49 -13.85 -83.65 2.38 -11.51 -3.79 -42.15 -2.30 -24.20 -13.52
NOPAT Less CapEx to Interest Expense
-6.66 -14.20 -11.05 -7.65 -17.78 -4.32 -3.99 -13.52 -3.56 -13.91 -7.51
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-1.51% -0.22% 0.00% -1.73% -4.87% -7.32% -9.09% -7.31% -6.59% -5.81% -6.69%
Augmented Payout Ratio
-66.82% -35.14% 0.00% -62.86% -79.22% -81.94% -9.09% -34.26% -55.90% -66.72% -81.71%

Financials Breakdown Chart

Key Financial Trends

Cannae Holdings (NYSE: CNNE) continues to show a mixed financial picture, with strong liquidity and large investment assets offset by persistent losses, weak operating cash flow, and heavy use of capital returns and portfolio activity. Over the last four years, the company’s results have been highly influenced by investment gains and losses, acquisitions/divestitures, and treasury stock activity rather than stable operating profitability.

  • Liquidity remains solid. As of Q1 2026, Cannae held $135.7 million in cash and equivalents, with total current assets of $208.7 million.
  • The balance sheet is asset-heavy. CNNE reported $1.24 billion in total assets in Q1 2026, including $809.5 million in long-term investments and $108.7 million in noncurrent note and lease receivables.
  • Equity remains substantial. Total equity and noncontrolling interests were $922.4 million in Q1 2026, which provides some financial flexibility.
  • Operating cash flow was positive in some prior periods. CNNE generated $16 million in operating cash flow in Q4 2025 and $9.1 million in Q1 2025, showing the business can occasionally produce cash from operations.
  • Divestitures and investment sales have at times supported cash generation. In several quarters, asset sales produced meaningful investing cash inflows, including $416.3 million in Q3 2025 and $84.5 million in Q2 2025.
  • Revenue has been fairly stable but not growing meaningfully. Q1 2026 revenue was $96.2 million, down from $103.3 million in Q4 2025 and $106.9 million in Q3 2025.
  • Gross margin is thin. Q1 2026 gross profit was only $1.1 million on $96.2 million of revenue, indicating limited operating cushion.
  • Net income is heavily affected by non-operating items. Large “other income/expense” and investment-related gains or losses have driven earnings swings across periods, making results volatile and less predictable.
  • Debt levels are manageable but not negligible. Q1 2026 showed $70.3 million of total debt, including $5.8 million short-term debt and $64.5 million long-term debt.
  • Share count has trended lower. CNNE has spent heavily on repurchases over time, which can support per-share metrics but also consumes cash.
  • Operating losses remain persistent. CNNE reported an operating loss of $22.1 million in Q1 2026, following a $24.1 million operating loss in Q4 2025 and a $13.2 million operating loss in Q3 2025.
  • Net losses continue to be sizable. Q1 2026 consolidated net loss was $35.8 million, and losses were much larger in prior quarters, including $98.6 million in Q4 2025 and $70.8 million in Q3 2025.
  • Operating cash flow turned sharply negative in Q1 2026. The company used $21.2 million in operating cash, after generating $16 million in Q4 2025.
  • Financing cash outflows are substantial. In Q1 2026, CNNE used $23.3 million in financing cash, largely due to $14.7 million in share repurchases and $6.9 million in dividend payments.
  • Cash balance declined sharply from the prior quarter. Cash and equivalents fell from $233.8 million at Q3 2025 to $135.7 million at Q1 2026.
  • Recent periods show volatile cash generation and capital allocation. Large swings in investing cash flow, driven by acquisitions, divestitures, and investment activity, make the company’s near-term cash profile difficult to forecast.

Bottom line: Cannae’s financial statements suggest a company with a meaningful asset base and decent liquidity, but one that is still struggling to produce consistent operating profits or stable free cash flow. For investors, the key question is whether CNNE can improve core business profitability and reduce reliance on investment and transaction-driven results.

07/14/26 03:07 PM ETAI Generated. May Contain Errors.

Cannae Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cannae's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cannae's net income appears to be on an upward trend, with a most recent value of -$524.90 million in 2025, rising from -$7.30 million in 2015. The previous period was -$310.10 million in 2024. Find out what analysts predict for Cannae in the coming months.

Cannae's total operating income in 2025 was -$119.60 million, based on the following breakdown:
  • Total Gross Profit: -$8.20 million
  • Total Operating Expenses: $111.40 million

Over the last 10 years, Cannae's total revenue changed from $1.41 billion in 2015 to $423.60 million in 2025, a change of -70.1%.

Cannae's total liabilities were at $329.80 million at the end of 2025, a 20.3% decrease from 2024, and a 28.8% decrease since 2016.

In the past 9 years, Cannae's cash and equivalents has ranged from $85.80 million in 2021 to $724.70 million in 2020, and is currently $182 million as of their latest financial filing in 2025.

Over the last 10 years, Cannae's book value per share changed from 0.00 in 2015 to 20.53 in 2025, a change of 2,053.4%.



Financial statements for NYSE:CNNE last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners